Stocks had a Fine Finish to a Rough Week
Recap - After a mostly red week, stocks gapped higher Friday morning with the latest jobs report. The jobless rate fell to 5.4%, the lowest since 2008, and a … Continue Reading
Read nowRecap - After a mostly red week, stocks gapped higher Friday morning with the latest jobs report. The jobless rate fell to 5.4%, the lowest since 2008, and a … Continue Reading
Read nowResearch - Even with Alexion Pharmaceuticals (ALXN) announcing Wednesday morning the acquisition of Synageva (GEVA) for a heady $8 billion, aggressive dip-buyers are still absent in the … Continue Reading
PremiumRecap - What a week. The iShares NASDAQ Biotechnology (IBB) made new all-time highs and is drastically outpacing the S&P 500, as well as the NASDAQ composite, for the … Continue Reading
Read nowResearch - Investors are skittish again, and healthcare investors more than others. Here’s why. In the Fed’s semi-annual monetary policy report, which accompanied Chairwoman Janet Yellen’s testimony before … Continue Reading
PremiumInsights - It’s New Year’s Eve. This year flew past – and so did biotech. The NASDAQ Biotechnology Index (NBI) will end the year up 60%, while … Continue Reading
Read nowResearch - We’ve watched AcelRx Pharmaceuticals (ACRX) for some time in 2013 as the stock has pulled back meaningfully, falling from a high of over $13 to … Continue Reading
Premium